A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors

NCT01182883 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Brain Stem Neoplasms
Glioma
Pinealoma

Interventions

DRUG: IMC-A12
DRUG: Temsirolimus

Sponsor

National Cancer Institute (NCI)